title: Neuroprotection for Parkinson's disease: prospects and promises.
authors.forename: C Warren
authors.initials: CW
authors.lastname: Olanow
authors.forename: Anthony H V
authors.initials: AH
authors.lastname: Schapira
authors.forename: Yves
authors.initials: Y
authors.lastname: Agid
mesh_terms: D000662:Amphetamines / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D009414:Nerve Growth Factors / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000627:therapeutic use*
chemical_list: D000662:Amphetamines; C495039:GDNF protein, human; D051100:Glial Cell Line-Derived Neurotrophic Factor; D008996:Monoamine Oxidase Inhibitors; D009414:Nerve Growth Factors; D018696:Neuroprotective Agents; D012642:Selegiline; C017861:desmethylselegiline